An open-label study of botulinum toxin A for treatment of tardive dystonia

D. Tarsy, D. Kaufman, K. D. Sethi, M. H. Rivner, E. Molho, S. Factor

Research output: Contribution to journalArticle

56 Scopus citations



  • Botulinum toxin
  • Neuroleptic drugs
  • Tardive dyskinesia
  • Tardive dystonia

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this